臨床眼科67巻11号

2013年10月発行

特集 図で早わかり 実戦！眼科薬理 Ⅱ．眼科臨床薬理各論 5．網膜疾患

硝子体手術と可視化剤

著者： 久冨智朗¹ 江内田寛²

所属機関： ¹国立病院機構九州医療センター・臨床研究センター ²九州大学大学院医学研究院眼科学分野

ページ範囲：P.265 - P.269

POINT

◎硝子体可視化法の歴史を理解し，適切な適用を考慮する。

◎目的に応じた可視化剤の選択と使用法を理解する。

◎可視化剤のメリット，デメリットを理解して有効に利用する。

参考文献

1）Peyman GA, Cheema R, Conway MD et al：Triamcinolone acetonide as an aid to visualization of the vitreous and the posterior hyaloid during pars plana vitrectomy. Retina　20：554-555, 2000

2）Sakamoto T, Miyazaki M, Hisatomi T et al：Triamcinolone-assisted pars plana vitrectomy improves the surgical procedures and decreases the postoperative blood-ocular barrier breakdown. Graefes Arch Clin Exp Ophthalmol　240：423-429, 2002

3）Yamakiri K, Sakamoto T, Noda Y et al：Reduced incidence of intraoperative complications in a multicenter controlled clinical trial of triamcinolone in vitrectomy. Ophthalmology　114：289-296, 2007

4）Kaji Y, Hiraoka T, Okamoto F et al：Visualizing the vitreous body in the anterior chamber using 11-deoxycortisol after posterior capsule rupture in an animal model. Ophthalmology　111：1334-1339, 2004

5）Yamashita T, Sakamoto T, Yamakiri K et al：Polylactic acid for visualizing the vitreous body during vitrectomy. Invest Ophthalmol Vis Sci　48：3277-3282, 2007

6）Kadonosono K, Itoh N, Uchio E et al：Staining of internal limiting membrane in macular hole surgery. Arch Ophthalmol　118：1116-1118, 2000

7）Burk SE, Da Mata AP, Snyder ME et al：Indocyanine green-assisted peeling of the retinal internal limiting membrane. Ophthalmology　107：2010-2014, 2000

8）Enaida H, Sakamoto T, Hisatomi T et al：Morphological and functional damage of the retina caused by intravitreous indocyanine green in rat eyes. Graefes Arch Clin Exp Ophthalmol　240：209-213, 2002

9）Ueno A, Hisatomi T, Enaida H et al：Biocompatibility of brilliant blue G in a rat model of subretinal injection. Retina　27：499-504, 2006

10）Enaida H, Sakamoto T, Hisatomi T et al：Morphological and functional damage of the retina caused by intravitreous indocyanine green in rat eyes. Graefes Arch Clin Exp Ophthalmol　240：209-213, 2002

11）Hisatomi T, Enaida H, Matsumoto H et al：The biocompatibility of Brilliant Blue G：Preclinical Study of Brilliant Blue G as an adjunct for capsular staining. Arch Ophthalmol　124：514-519, 2006

12）Enaida H, Hisatomi T, Hata Y et al：Brilliant blue G selectively stains the internal limiting membrane；brilliant blue G-assisted membrane peeling. Retina　26：631-636, 2006

13）Enaida H, Ishibashi T：Brilliant blue in vitreoretinal surgery. Dev Ophthalmol　42：110-120, 2008

14）Notomi S, Hisatomi T, Kanemaru T et al：Critical involvement of extracellular ATP acting on P2RX7 purinergic receptors in photoreceptor cell death. Am J Pathol　179：2798-2809, 2011

15）Notomi S, Hisatomi T, Murakami Y et al：Dynamic increase in extracellular ATP accelerates photoreceptor cell apoptosis via ligation of P2RX7 in subretinal hemorrhage. PLoS One　8：e53338, 2013